Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or
Standard; Transfer of Listing.
On July 8, 2022, Creative Medical Technology Holdings, Inc. (the "Company")
received a letter from The Nasdaq Stock Market stating that the Company was not
in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price
of the Company's common stock was below $1.00 per share for 30 consecutive
business days. The notice has no immediate impact on the Company's listing.
Pursuant to Nasdaq's Listing Rules, the Company has a 180 day grace period,
until January 4, 2023, during which the Company may regain compliance if the bid
price of its common stock closes at $1.00 per share or more for a minimum of ten
consecutive business days. The Company may be eligible for an additional 180-day
grace period if the Company meets Nasdaq's initial listing standards (other than
with respect to minimum bid price) for The Nasdaq Capital Market.
The Company intends to actively monitor the bid price for its common stock
between now and January 4, 2023, and will consider available options to regain
compliance with the Nasdaq minimum bid price requirements.
2
© Edgar Online, source Glimpses